Procter & Gamble reported adjusted earnings per share of $1.88 for its fiscal second quarter, modestly above the consensus estimate of $1.86, driven by gross margin expansion and favorable tax impacts. Total revenue reached $22.21 billion, up 1.5% year-over-year, though slightly shy of the $22.36 billion consensus. The company delivered a net margin of 19.7% and returned on equity of 32.6%. Management reiterated full-year adjusted EPS guidance of $6.83–$7.09, reflecting confidence in H2 acceleration, and expects organic sales growth to be flat to +4%, with neutral commodity costs and a modest foreign-exchange tailwind.

During the quarter, Procter & Gamble generated operating cash flow of approximately $5.0 billion and achieved adjusted free-cash-flow productivity of 88% of net earnings. The company returned $4.8 billion to shareholders, comprising $2.5 billion in dividends and $2.3 billion in share repurchases. The announced quarterly dividend of $1.0568 per share represents a 4.23 annualized payout and a yield near 2.8%, supporting the firm’s 61.8% payout ratio and its status as a dividend king.

P&G’s Baby Care segment faced unit volume declines globally but delivered a 20% organic sales increase in Greater China, led by the Pampers Prestige line featuring silk-fiber technology to enhance skin comfort. This premiumization strategy contributed to a 3% market-share gain in the region over 18 months. Across categories, Skin Care in Greater China also outperformed on higher-margin formulations and pricing, underscoring the company’s focus on innovation-led growth in its second-largest market.